UnknownPhase 4

Comparative Study of Polidocanol and Absolute Alcohol for Percutaneous us Guided Treatment of Benign Thyroid Cyst

30 participantsStarted 2023-04-01

Plain-language summary

This study aims to compare the efficacy and safety of ultrasound-guided percutaneous ethanol injection and percutaneous polidocanol injection for the treatment of benign cystic and predominantly cystic thyroid nodules.

Who can participate

Age range10 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Single cystic or predominantly cystic nodules. * Pressure symptoms or cosmetic problems. * No malignant or indeterminate cytologic results after ultrasound-guided fine-needle aspiration. * Normal serum thyroid hormone levels Exclusion Criteria: * Association of a nodules showing malignant features on us examinations. * Malignant or indeterminate cytologic results after ultrasound-guided fine-needle aspiration. * Abnormal serum thyroid hormone levels

What they're measuring

Size of the thyroid cystic nodule after sclerosing agent injection (polidocanol versus alcohol)

Timeframe: 3 months

Trial details

NCT IDNCT05798936

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-01

Contact for this trial

Amna Ahmed

01095339383 amnabkar76@gmail.com

View on ClinicalTrials.gov More Benign Thyroid Nodule trials